News – Page 6 – PharmaKorell

Benefits at PharmaKorell

In addition to working on interesting international projects that have life-changing impact on patients, we value the informal professional company culture at PharmaKorell. However, this does not mean that we forego the benefits that are typically associated with large corporations.

At PharmaKorell, we offer flexible and family-friendly work schedules, company pensions, support for childcare costs, relocation assistance, company cars for senior consultants, permanent employment contracts, full compensation for overtime, and the option to work from both the office and home.

Currently, we are having a workshop to identify additional benefits that may be important to our team. What benefits do you think make a big difference?

News - 05/03/2023

New meeting room in Lörrach

Our monthly Jour Fixe is always an important date in our calendar. We are excited to gather in our large new meeting room in Lörrach, which was created by removing a wall.
Our staff count has grown by 50% within a year. Although our larger new table is still being custom-made (the picture shows the old meeting table), we are already pleased with the additional space available.

News - 05/03/2023

New PharmaKorell office in Munich receives Manufacturing and Import Authorisation

We are pleased to announce that our new location in Munich has successfully passed the inspection by the Government of Upper Bavaria and now holds its own Manufacturing and Import Authorisation (MIA) for drug products. This means that we are now able to offer QP batch certification in Munich - one of the most important pharmaceutical hubs in Europe.

PharmaKorell has been holding a MIA in Baden-Württemberg (Lörrach) since 2013. The additional MIA in Munich further strengthens our flexibility and efficiency during the certification process. Batch certificates issued by our Lörrach and our Munich office are valid and recognised throughout the entire European Union and the EEA. Furthermore, we are authorised to certify batches for use in clinical trials in the United Kingdom and Switzerland.

News - 04/27/2023

Bentornata in PharmaKorell, Dott.ssa Lucia Vitellozzi!

The company is delighted to welcome back Lucia Vitellozzi to the team as from today. Lucia has previously worked at PharmaKorell from 2018 to 2021, and is now rejoining us - this time primarily in the role of Business Development with focus on Italy.

With her international work experience and solid background in pharmaceutical quality management, Lucia is not only a valued team member but also a perfect addition to our multidisciplinary team. We are thrilled to be working together with Lucia on exciting projects again.

News - 04/21/2023

A warm welcome to our team, Dr. Stephanie Olbrich!

We are excited to welcome our new Senior Consultant and Qualified Person, Dr. Stephanie Olbrich, to PharmaKorell! As a PhD in Natural Sciences and M.Sc. in Chemistry from the Chemnitz University of Technology and with experience since 2011 in companies like Novartis AG and Sandoz GmbH, Stephanie brings valuable knowledge and expertise to our team.

Stephanie has worked in various areas such as team lead analytics, project management, batch release, GMP compliance, and validation. Stephanie is also experienced in employee GMP training, product quality reviews, batch record review, and monitoring process parameters. Her comprehensive know-how in OOS, CAPA and deviation management, change control, process performance qualification, and many other areas is a real asset to our team!

News - 04/06/2023

PharmaKorell is expanding its executive board

We are very pleased to announce that Dr. Frank Wienen will be appointed as Managing Director of Pharmakorell GmbH on April 1, 2023. He will join the management team of the rapidly growing PharmaKorell GmbH in April and lead the company together with Dr. Ulrich Korell.

Dr. Wienen is a qualified pharmacist and specialist in pharmaceutical analytics, with a PhD in pharmacy. He has been working as a senior consultant and qualified person (AMG §14) at PharmaKorell since 2021. Prior to that, he worked for 18 years in various areas of expertise at Novartis, Bayer, and Roche, and brings extensive management experience to the table.

Dr. Wienen will now play a key role in the further development of our company. We are thrilled that he will significantly strengthen the management of PharmaKorell GmbH and wish him all the best and continued success in his new role!

News - 03/27/2023

Training at PharmaKorell

Continuing education is essential in the broad field of medicinal products. Dr. Cora Büttner is currently participating in a two-part training by CONCEPT HEIDELBERG GmbH covering the following topics:

• GMP for medical devices
• Qualification and validation in the area of medical devices.

But why are these topics relevant for a pharmacist and Qualified Person (AMG) for medicinal products?

“Upon closer examination, it becomes clear that medical devices and medicinal products are two distinct worlds, with different regulations governing quality requirements, the approval process, and inspections by authorities.

Exactly these two worlds meet each other, if you combine a medical device with a medicinal product – to get a 'combination product'. Here the application system for the drug plays a very important role.

Combination products pose a challenge for us to meet the requirements of both product groups and find a pragmatic solution to reconcile all requirements. As a qualified person at the end of the manufacturing chain, we certify these products.

Thankfully, in-person training is now possible after a long period of virtual seminars. On-site training has the advantage of allowing for face-to-face discussions during workshops, Q&A sessions, and, of course, coffee breaks 🙂. Both trainers and trainees agree on the benefits of this format.”

News - 02/17/2023

Thank you to the administration team

We'd like to extend our gratitude to Asta Handke, Dietmar Holz, and Christiane Maise, from the administrative team. Their invaluable assistance has allowed us to provide top-notch consulting to our clients. They are a crucial component of our team, and we're thankful for their contributions. Their reliability and dedication is greatly appreciated.

News - 02/09/2023

Gabriele-Wanninger-Welcome-Linkedin-1080x1080

Welcome to the team!

We are overjoyed to welcome Dr. Gabriele Wanninger to our team today. She will be bringing her wealth of knowledge and experience into her new role as Lead Auditor and Senior Consultant.

Since 1988, Dr. Gabriele Wanninger has made a valuable contribution to the state of Bavaria through her work in pharmaceutical analytics and as a GMP, GDP, and GCP inspector. She was a member of expert groups at the German Central Authority of the States for Health Protection and contributed to quality assurance in pharmaceutical supervision. She participated in projects of the European Commission and brought her experience into pharmaceutical improvement projects in Asia and Africa.

With a confident smile, Dr. Gabriele Wanninger speaks about her new role at PharmaKorell "After many years in the field of pharmaceutical monitoring, I am enthusiastic about utilizing my expertise to offer the highest level of support to pharmaceutical companies."

News - 02/02/2023

Team PharmaKorell enjoys flexi-time

At PharmaKorell, our employees enjoy flexi-time without set core hours. This allows the team to choose their working hours and adapt them to their personal life choices.

Sitting for too long affects cognitive ability. Enjoying the sun's rays, going for a stroll, taking advantage of an empty yoga class, or squeezing in a bike ride before sunset?

We prioritise self-responsible work and work-life balance. This benefits both our clients and our team.

Photo by David Marcu on Unsplash

News - 01/20/2023